Current market size for contact lenses is totally irrelevant imo. We are talking about therapeutic lenses or lenses designed to provide a diagnosis, which is an entirely new market. EPGL tech is not there to compete with existing lenses, or glasses. We must consider the market of glucose monitoring, DMLA treatment etc. etc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.